A Report from the 54th Annual Meeting of the European Society for Dermatological Research (ESDR).
The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
View ReportWelcome the newest leadership to the IPC Board of Directors! Meet incoming IPC President Bruce Strober, Vice…
Read MoreThe 2024 IPC Think Tank Congress Report provides a comprehensive summary of key topics, including the epidemiology of…
Read MoreThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreGeneralized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…
View ReportRead key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting, summarizing the evolving…
Read MoreAccess the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in…
Read MoreIPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from…
Read MoreThe IPC Board of Directors is pleased to announce that it has named Hervé Bachelez, MD, PhD, as its newly appointed…
Read MoreThe European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…
Read MoreEUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) | BERLIN, GERMANY Wednesday, October 11 8:30 – 11:45 am…
Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The…
View ReportThe 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN) was held Wednesday, July 6 –…
Read MoreIPC's newly appointed appointed officers take their roles beginning January 1, 2022.
Read MoreThe European Academy of Dermatology and Venerelogy 30th Annual Congress (EADV) was packed with science and clinical…
Read MoreThomas Sharnitz, MD, has written the report, summarizing the most important presentations with a focus on psoriasis…
View ReportRecently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19…
Read MoreView Report
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.